| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151147C Indole derivatives as 5-HT receptor antagonist |
| 05/26/2004 | CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists |
| 05/26/2004 | CN1151140C Glucokinase activators |
| 05/26/2004 | CN1151139C Novel heterocyclic analogs of diphenylethylene compounds |
| 05/26/2004 | CN1151138C Triazole antifungal agent |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1151130C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 05/26/2004 | CN1151129C 2-acryl-3-substituted indoacetamide derivative and its medical application |
| 05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 05/26/2004 | CN1151126C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 05/26/2004 | CN1151125C Compounds and methods for treatment of cardiovascular, imflammatory and immune disorders |
| 05/26/2004 | CN1151122C Tramadol, Salts thereof and process for their preparation |
| 05/26/2004 | CN1150935C Naoan brain care capsule and preparation process thereof |
| 05/26/2004 | CN1150925C Chinese Patent medicine for curing deafness |
| 05/26/2004 | CN1150923C Medicine for treating stomatocase |
| 05/26/2004 | CN1150918C Medicine containing active components of Panax japonicum foot and preparing process |
| 05/26/2004 | CN1150917C Medicine containing active components of rhodiola crenulata root and preparig process thereof |
| 05/26/2004 | CN1150915C Prescription of'strong heart first-aid dropping pill'and its preparing process |
| 05/26/2004 | CN1150913C Chinese patent drug for treating peridentitis |
| 05/26/2004 | CN1150905C Nonatungsten trititanium silicate used as antineoplastic medicine |
| 05/26/2004 | CN1150903C Peritoneal dialysis solution containing modified icodextrins |
| 05/26/2004 | CN1150902C Prescription of preparing moxapride citrate |
| 05/26/2004 | CN1150901C Use of 1-ar (alk)yl-imidazoline-2-one for treating anxietyand stress conditions |
| 05/26/2004 | CN1150900C Pharmaceutical compositions for oral administration, comprising active substance and cyclodextrin |
| 05/26/2004 | CN1150899C Chinese medicine-psoralen preparation used in preparing medicine |
| 05/26/2004 | CN1150898C Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthrits, neurodermatitis and regional enterits |
| 05/26/2004 | CN1150897C Injectable composition of non-steroidal anti-inflammatory drugs |
| 05/26/2004 | CN1150896C New medicine use of 6-methoxy-2-2delta 10'-cis-heptadecene-1,4 benzoquinone |
| 05/26/2004 | CN1150895C Dry Powder for inhalation |
| 05/26/2004 | CN1150893C Pharmaceutical compsn. having two coating layers |
| 05/26/2004 | CN1150890C Medicinal aerosol formulations |
| 05/26/2004 | CN1150889C Oral Micro-emulsion composition of silybin |
| 05/26/2004 | CN1150888C Peroral active agent suspension |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740775 Purity; stability; dissolving pravastatin salt in lower alcohol; adding ethyl acetate and cooling |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740750 Ribozyme sequences related to hiv resistance |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740680 Pharmaceutical compositions to tetrac and methods of use thereof |
| 05/25/2004 | US6740679 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| 05/25/2004 | US6740678 Screening; administering angiogenesis inhibitor |
| 05/25/2004 | US6740677 Anxiety, convulsions |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740674 Administering formulation comprising proteasome inhibitor in carrier for therapy of dry eye disorder |
| 05/25/2004 | US6740673 Quarternary ammonium compounds |
| 05/25/2004 | US6740672 Administering alosetron, tropisetron, ondansetron, granisetron and/or bemesetron |
| 05/25/2004 | US6740670 Thiazolidine derivatives and its use as antifungal agent |
| 05/25/2004 | US6740669 Varying solvent and/or duration of recrystallization; rufinamide orange book listed patent |
| 05/25/2004 | US6740668 Methods for inhibiting diabetic complications |
| 05/25/2004 | US6740667 Antimicrobial agent |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740665 Tyrosine kinase inhibitors and methods of using the same |
| 05/25/2004 | US6740664 A new class of quinolone antibiotic (e.g., moxifloxacin) is useful for treating otic, opthalmic or nasal infections attributed to a microbacterium species selected from microbacterium otitidis or microbacterium alconae |
| 05/25/2004 | US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 05/25/2004 | US6740662 Having 2-oxo-1,2-dihydro- functionality; phosphodiesterase inhibitors |
| 05/25/2004 | US6740660 For amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to mammal |
| 05/25/2004 | US6740659 Treatment of dyskinesia |
| 05/25/2004 | US6740657 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 05/25/2004 | US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740654 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells. |
| 05/25/2004 | US6740653 An oil in water emulsion comprising an alkaline to increase the solubility of aza compound; control infestations, infections of livestock or domestic animals; topical application, veterinary medicine |
| 05/25/2004 | US6740652 Topical administration of an ophthalmologically effective amount of an oxazolidinone derivative |
| 05/25/2004 | US6740648 Using a vasopressin antagonist such as conivaptan |
| 05/25/2004 | US6740646 Bioavailable prodrugs of androgenic steroids and related method |
| 05/25/2004 | US6740645 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
| 05/25/2004 | US6740644 Chemical compounds |
| 05/25/2004 | US6740642 Macrolides with antibacterial activity |
| 05/25/2004 | US6740641 Administering to a patient for treatment of the pain a glucoside or glucuronide derivative of hydromorphone, dihydromorphine, or dihydroisomorphine or a pharmaceutically acceptable salt |
| 05/25/2004 | US6740636 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| 05/25/2004 | US6740515 Recombinant adenovirus |
| 05/25/2004 | US6740339 Preparation comprising active ingredient, saccharide or sugar alcohol with mean particle diameter of 5 mu m up to 90 mu m, saccharide or sugar alcohol with mean particle diameter of 90 mu m to 500 mu m, disintegrating agent, and cellulose compound |
| 05/25/2004 | US6740337 Stability |
| 05/25/2004 | US6740335 Liposomal camptothecin formulations |
| 05/25/2004 | US6740334 Bone resorption suppressing agent |
| 05/25/2004 | US6740330 Method of treating acne vulgaris and composition |
| 05/25/2004 | US6740327 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 05/25/2004 | US6740326 Water-free topical application composition for treatment of nail diseases and nail care consisting of antimycotic agent and lower alkyl ester of lactic acid, malic acid, tartaric acid or citric acid as penetration promoting carrier |
| 05/25/2004 | US6740310 Porous particles comprising excipients for deep lung delivery |
| 05/25/2004 | US6740309 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/25/2004 | US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products |
| 05/25/2004 | US6740307 Delivery of β-blockers through an inhalation route |
| 05/25/2004 | US6740306 Imidazotriazinone-containing compositions for nasal administration |
| 05/25/2004 | CA2267497C Edible, low calorie compositions of a carrier and an active ingredient and methods for preparation thereof |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/25/2004 | CA2260795C Synthetic protein folding catalysis |
| 05/25/2004 | CA2185457C Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 05/25/2004 | CA2153681C Topical ketoconazole compositions |
| 05/25/2004 | CA2149777C New steroids |
| 05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
| 05/25/2004 | CA2101871C Transdermic pharmaceutical preparation |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/25/2004 | CA2046337C Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions |
| 05/25/2004 | CA2029419C Nmda-blocking pharmaceutical compositions |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004042348A2 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenetetrahydrofolate reductase as antibiotics |
| 05/21/2004 | WO2004042080A1 Cancer therapy determination |